Assessing the effect of HAART on change in quality of life among HIV-infected women

AIDS Research and Therapy

Volumn 3, Issue 1, 2006, Pages

  Liu, Chenglong ^a,b   Weber, Kathleen ^c   Robison, Esther ^d   Hu, Zheng ^a   Jacobson, Lisa P ^a   Gange, Stephen J ^a  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Jr Hospital of Cook County   (United States)

^d MONTEFIORE MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABACAVIR; ANTIRETROVIRUS AGENT; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR; STAVUDINE; TENOFOVIR; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; CLINICAL TRIAL; COGNITION; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DATA ANALYSIS; DEMOGRAPHY; DRUG UTILIZATION; FEMALE; FOLLOW UP; HEALTH STATUS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MULTICENTER STUDY; NOCICEPTION; OUTCOME ASSESSMENT; PHYSICAL CAPACITY; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SOCIAL STATUS; SOCIOECONOMICS; UNITED STATES;

EID: 33747802064     PISSN: 17426405     EISSN: None     Source Type: Journal    
DOI: 10.1186/1742-6405-3-6     Document Type: Article

References (32)

1. Hays RD, Cunningham WE, Sherbourne CD, Wilson IB, Wu AW, Cleary PD, McCaffrey DF, Fleishman JA, Crystal S, Collins R, Eggan F, Shapiro MF, Bozzette SA: Health-related quality of life in patients with human immunodeficiency virus infection in the United States: results from the HIV Cost and Services Utilization Study. Am J Med 2000, 108(9):714-722.
2. Detels R, Munoz A, McFarlane G, Kingsley LA, Margolick JB, Giorgi J, Schrager LK, Phair JP: Effectiveness of potent antiretroviral therapy on time to AIDS and death in men with known HIV infection duration. Multicenter AIDS Cohort Study Investigators. Jama 1998, 280(17):1497-1503.
3. Gange SJ, Barron Y, Greenblatt RM, Anastos K, Minkoff H, Young M, Kovacs A, Cohen M, Meyer WA, Munoz A: Effectiveness of highly active antiretroviral therapy among HIV-I infected women. J Epidemiol Community Health 2002, 56(2):153-159.
4. Palella FJJ, Delaney KM, Moorman AC, Loveless MO, Fuhrer J, Satten GA, Aschman DJ, Holmberg SD: Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med 1998, 338(13):853-860.
5. Carrieri P, Spire B, Duran S, Katlama C, Peyramond D, Francois C, Chene G, Lang JM, Moatti JP, Leport C: Health-related quality of life after 1 year of highly active antiretroviral therapy. J Acquir Immune Defic Syndr 2003, 32(1):38-47.
6. Nieuwkerk PT, Gisolf EH, Colebunders R, Wu AW, Danner SA, Sprangers MA: Quality of life in asymptomatic- and symptomatic HIV infected patients in a trial of ritonavir/saquinavir therapy. The Prometheus Study Group. Aids 2000, 14(2):181-187.
7. Gill CJ, Griffith JL, Jacobson D, Skinner S, Gorbach SL, Wilson IB: Relationship of HIV viral loads, CD4 counts, and HAART use to health-related quality of life. J Acquir Immune Defic Syndr 2002, 30(5):485-492.
8. Zinkernagel C, Ledergerber B, Battegay M, Cone RW, Vernazza P, Hirschel B, Opravil M: Quality of life in asymptomatic patients with early HIV infection initiating antiretroviral therapy. Swiss HIV Cohort Study. Aids 1999, 13(12):1587-1589.
9. Chan KS, Orlando M, Ghosh-Dastidar B, Duan N, Sherbourne CD: The interview mode effect on the Center for Epidemiological Studies Depression (CES-D) scale: an item response theory analysis. Med Care 2004, 42(3):281-289.
10. Low-Beer S, Chan K, Wood E, Yip B, Montaner JS, O'Shaughnessy MV, Hogg RS: Health related quality of life among persons with HIV after the use of protease inhibitors. Qual Life Res 2000, 9(8):941-949.
11. Nieuwkerk PT, Gisolf EH, Reijers MH, Lange JM, Danner SA, Sprangers MA: Long-term quality of life outcomes in three antiretroviral treatment strategies for HIV-1 infection. Aids 2001, 15(15):1985-1991.
12. Saunders DS, Burgoyne RW: Evaluating health-related wellbeing outcomes among outpatient adults with human immunodeficiency virus infection in the HAART era. Int J STD AIDS 2002, 13(10):683-690.
13. Gandhi M, Ameli N, Bacchetti P, Sharp GB, French AL, Young M, Gange SJ, Anastos K, Holman S, Levine A, Greenblatt RM: Eligibility criteria for HIV clinical trials and generalizability of results: the gap between published reports and study protocols. Aids 2005, 19(16):1885-1896.
14. Gifford AL, Cunningham WE, Heslin KC, Andersen RM, Nakazono T, Lieu DK, Shapiro MF, Bozzette SA: Participation in research and access to experimental treatments by HIV-infected patients. N Engl J Med 2002, 346(18):1373-1382.
15. CDC: HIV prevention in the third decade.
16. Ahdieh L, Gange SJ, Greenblatt R, Minkoff H, Anastos K, Young M, Nowicki M, Kovacs A, Cohen M, Munoz A: Selection by indication of potent antiretroviral therapy use in a large cohort of women infected with human immunodeficiency virus. Am J Epidemiol 2000, 152(10):923-933.
17. Burgoyne RW, Rourke SB, Behrens DM, Salit IE: Long-term quality-of-life outcomes among adults living with HIV in the HAART era: the interplay of changes in clinical factors and symptom profile. AIDS Behav 2004, 8(2):151-163.
18. Barkan SE, Melnick SL, Preston-Martin S, Weber K, Kalish LA, Miotti P, Young M, Greenblatt R, Sacks H, Feldman J: The Women's Inter-agency HIV Study. WIHS Collaborative Study Group. Epidemiology 1998, 9(2):117-125.
19. Bozzette SA, Hays RD, Berry SH, Kanouse DE, Wu AW: Derivation and properties of a brief health status assessment instrument for use in HIV disease. J Acquir Immune Defic Syndr Hum Retrovirol 1995, 8(3):253-265.
20. DHHS/Henry J. Kaiser family foundation panel on clinical practices for the treatment of HIV infection. Guidelines for the use of antiretroviral agents in HIV-infected adults and adolescents. April 2005 revision. Available at http://aids-info.nih.gov. Accessed March 1, 2006.
21. Calvelli T, Denny TN, Paxton H, Gelman R, Kagan J: Guideline for flow cytometric immunophenotyping: a report from the National Institute of Allergy and Infectious Diseases, Division of AIDS. Cytometry 1993, 14(7):702-715.
22. Radloff LS: The CESD scale: A self-report depression scale for research in the general population. Appl Psychological Measurement 1977:385-401.
23. Rosenbaum PRRDB: The central role of the propensity score in observational studies for causal effects. Biometrika 1983, 70:41-55.
24. Little RJ, Wang Y: Pattern-mixture models for multivariate incomplete data with covariates. Biometrics 1996, 52(1):98-111.
25. Hogan JW, Roy J, Korkontzelou C: Handling drop-out in longitudinal studies. Stat Med 2004, 23(9):1455-1497.
26. Miners AH, Sabin CA, Mocroft A, Youle M, Fisher M, Johnson M: Health-related quality of life in individuals infected with HIV in the era of HAART. HIV Clin Trials 2001, 2(6):484-492.
27. Ostrow DE, Fox KJ, Chmiel JS, Silvestre A, Visscher BR, Vanable PA, Jacobson LP, Strathdee SA: Attitudes towards highly active antiretroviral therapy are associated with sexual risk taking among HIV-infected and uninfected homosexual men. Aids 2002, 16(5):775-780.
28. Cepeda MS, Boston R, Farrar JT, Strom BL: Comparison of logistic regression versus propensity score when the number of events is low and there are multiple confounders. Am J Epidemiol 2003, 158(3):280-287.
29. Wilson TE, Barron Y, Cohen M, Richardson J, Greenblatt R, Sacks HS, Young M: Adherence to antiretroviral therapy and its association with sexual behavior in a national sample of women with human immunodeficiency virus. Clin Infect Dis 2002, 34(4):529-534.
30. Wu AW, Mathews WC, Brysk LT, Atkinson JH, Grant I, Abramson I, Kennedy CJ, McCutchan JA, Spector SA, Richman DD: Quality of life in a placebo-controlled trial of zidovudine in patients with AIDS and AIDS-related complex. J Acquir Immune Defic Syndr 1990, 3(7):683-690.
31. Wu AW, Revicki DA, Jacobson D, Malitz FE: Evidence for reliability, validity and usefulness of the Medical Outcomes Study HIV Health Survey (MOS-HIV). Qual Life Res 1997, 6(6):481-493.
32. Little RJ, Wang Y: Pattern-mixture models for multivariate incomplete data with covariates. Biometrics 1996, 52:98-111.